Sponsor or institution
Clinical trials and research at Lantheus Medical Imaging
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Lantheus Medical Imaging that are recruiting, in United States. By phase: Phase 1/2 (2), Phase 2/3 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Dose optimization and imaging test for prostate cancer using a GRPR-targeted radiotracer | Phase 2/3 | Grand Rapids, Michigan | Recruiting | Sep 21, 2026 |
| 177Lu targeted therapy for relapsed or refractory osteosarcoma | Phase 1/2 | Los Angeles, California and 1 other locations | Recruiting | Jan 22, 2026 |
| Using 64Cu-LNTH-1363S for imaging in patients with sarcoma or gastrointestinal cancers | Phase 1/2 | Duarte, California and 4 other locations | Recruiting | Mar 7, 2024 |
| Assessing tau deposition in Alzheimer's disease using PET imaging | Phase 3 | Phoenix, Arizona and 24 other locations | Recruiting | Dec 8, 2022 |
All recruiting trials (4)
-
Dose optimization and imaging test for prostate cancer using a GRPR-targeted radiotracer
This study tests a GRPR-targeted PET imaging agent to optimize dose and timing for diagnosing newly diagnosed or high-risk prostate cancer before surgery.
-
177Lu targeted therapy for relapsed or refractory osteosarcoma
This trial will test LNTH-2403, a radioactive targeted drug using lutetium-177, to see if it can shrink or control tumors in people with relapsed or refractory osteosarcoma.
-
Using 64Cu-LNTH-1363S for imaging in patients with sarcoma or gastrointestinal cancers
This study is testing a new imaging agent called 64Cu-LNTH-1363S in patients with metastatic sarcoma or gastrointestinal cancers to see how safe it is and how well it works for imaging their tumors.
-
Assessing tau deposition in Alzheimer's disease using PET imaging
This study is testing a new type of brain scan to see if it can accurately detect tau buildup in people with Alzheimer's disease who have a serious illness and a limited life expectancy.
Quick answers
How many clinical trials run by Lantheus Medical Imaging are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.